Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Boylan

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Clinical Proteomics|January 3, 2024
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assayJoohyun Ryu, Kristin L M Boylan, Carly A I Twigg, et al.
Clinical Proteomics|October 21, 2017
A multiplex platform for the identification of ovarian cancer biomarkersKristin L M Boylan, Kate Geschwind, Joseph S Koopmeiners, et al.
Clinical Proteomics|January 8, 2021
Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomicsKristin L M Boylan, Somaieh Afiuni-Zadeh, Melissa A Geller, et al.
Journal of Translational Medicine|April 20, 2019
Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcomaKeith M Skubitz, Jon D Wilson, Edward Y Cheng, et al.
Fertility and Sterility|July 1, 1987
Pulsatile intravenous gonadotropin-releasing hormone for ovulation-induction in infertile women. II. Analysis of follicular and luteal phase responsesR P Jansen, D J Handelsman, L M Boylan, et al.
Cancer Research|May 8, 2007
A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myelomaKristin L M Boylan, Mary A Gosse, Sarah E Staggs, et al.
Oncotarget|December 31, 2016
The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferateKristin L M Boylan, Petra C Buchanan, Rory D Manion, et al.
The Journal of Biological Chemistry|February 25, 2017
Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17Petra C Buchanan, Kristin L M Boylan, Bruce Walcheck, et al.
Gynecologic Oncology|June 1, 2013
Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progressionAmy P N Skubitz, Elizabeth P Taras, Kristin L M Boylan, et al.
Biosensors & Bioelectronics|November 17, 2018
Development of a multiplexed giant magnetoresistive biosensor array prototype to quantify ovarian cancer biomarkersTodd Klein, Wei Wang, Lina Yu, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Clinical Proteomics|January 3, 2024
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assayJoohyun Ryu, Kristin L M Boylan, Carly A I Twigg, et al.
Clinical Proteomics|October 21, 2017
A multiplex platform for the identification of ovarian cancer biomarkersKristin L M Boylan, Kate Geschwind, Joseph S Koopmeiners, et al.
Clinical Proteomics|January 8, 2021
Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomicsKristin L M Boylan, Somaieh Afiuni-Zadeh, Melissa A Geller, et al.
Journal of Translational Medicine|April 20, 2019
Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcomaKeith M Skubitz, Jon D Wilson, Edward Y Cheng, et al.
Fertility and Sterility|July 1, 1987
Pulsatile intravenous gonadotropin-releasing hormone for ovulation-induction in infertile women. II. Analysis of follicular and luteal phase responsesR P Jansen, D J Handelsman, L M Boylan, et al.
Cancer Research|May 8, 2007
A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myelomaKristin L M Boylan, Mary A Gosse, Sarah E Staggs, et al.
Oncotarget|December 31, 2016
The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferateKristin L M Boylan, Petra C Buchanan, Rory D Manion, et al.
The Journal of Biological Chemistry|February 25, 2017
Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17Petra C Buchanan, Kristin L M Boylan, Bruce Walcheck, et al.
Gynecologic Oncology|June 1, 2013
Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progressionAmy P N Skubitz, Elizabeth P Taras, Kristin L M Boylan, et al.
Biosensors & Bioelectronics|November 17, 2018
Development of a multiplexed giant magnetoresistive biosensor array prototype to quantify ovarian cancer biomarkersTodd Klein, Wei Wang, Lina Yu, et al.
Pageof 6